Successful treatment of chronic myeloid leukemia with imatinib mesylate in a patient with chronic renal failure on hemodialysis
Authors:
Open Access
- 5 May 2006
- journal article
- letter
- Published by Wiley in American Journal of Hematology
- Vol. 81 (6) , 474
Abstract
No abstract availableThis publication has 5 references indexed in Scilit:
- Pharmacokinetics of imatinib mesylate in end stage renal disease. A case studyCancer Chemotherapy and Pharmacology, 2005
- Pharmacokinetics and Pharmacodynamics of Imatinib in a Phase I Trial With Chronic Myeloid Leukemia PatientsJournal of Clinical Oncology, 2004
- Imatinib mesylate therapy in patients with gastrointestinal stromal tumors and impaired liver functionAnti-Cancer Drugs, 2002
- Hematologic and Cytogenetic Responses to Imatinib Mesylate in Chronic Myelogenous LeukemiaNew England Journal of Medicine, 2002
- Efficacy and Safety of a Specific Inhibitor of the BCR-ABL Tyrosine Kinase in Chronic Myeloid LeukemiaNew England Journal of Medicine, 2001